Internal Medicine, Endocrinology, Diabetes, & Metabolism · Orlando, FL
NPI
1548424252
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
7485 Sandlake Commons Blvd
Orlando, FL, 32819
Phone (407) 574-5161
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
868 services
Medicare patients, 2024
213
Average age 74
Drug cost, 2024
$2.8M
5,372 prescriptions
Company payments, 2025
$5,253
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deepa Taneja was code 99214 (office e&m - established), 380 times for 172 patients. In total Deepa Taneja billed 868 services in 17 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 380 | 172 | $91.34 | $35K |
| 95251 Test - Miscellaneous | Office | 179 | 72 | $25.61 | $4,584 |
| 99213 Office E&M - Established | Office | 82 | 58 | $57.59 | $4,722 |
| 99215 Office E&M - Established | Office | 76 | 57 | $128.11 | $9,736 |
| 99204 Office E&M - New | Office | 42 | 42 | $130.11 | $5,465 |
| 76536 Ultrasound - Nonspecific | Office | 42 | 40 | $78.53 | $3,298 |
| 95250 Test - Miscellaneous | Office | 23 | 23 | $108.84 | $2,503 |
By year: 2022 $56K for 728 services; 2023 $70K for 881 services; 2024 $68K for 868 services.
Medicare prescription drug claims, 2024
In 2024, the drug Deepa Taneja prescribed most often to Medicare patients was Levothyroxine Sodium, with 406 prescriptions and refills. In total Deepa Taneja wrote 5,372 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 406 | 1,148 | 132 | $4,026 |
| Rosuvastatin Calcium Generic | 339 | 991 | 130 | $3,657 |
| Ozempic Semaglutide | 253 | 462 | 68 | $442K |
| Metformin Hcl Er Metformin Hcl | 221 | 591 | 79 | $1,436 |
| Omnipod Dash Pods (Gen 4) Insulin Pump Cart,cont Inf,bt | 221 | 449 | 56 | $299K |
| Nateglinide Generic | 208 | 412 | 73 | $7,133 |
| Ezetimibe Generic | 161 | 446 | 60 | $3,254 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 152 | 296 | 30 | $212K |
| Losartan Potassium Generic | 128 | 374 | 56 | $1,403 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 123 | 213 | 31 | $154K |
| Repatha Sureclick Evolocumab | 123 | 233 | 31 | $133K |
| Metformin Hcl Generic | 120 | 352 | 44 | $476 |
| Mounjaro Tirzepatide | 119 | 199 | 36 | $213K |
| Pioglitazone Hcl Generic | 111 | 300 | 41 | $1,118 |
| Novolog Insulin Aspart | 103 | 199 | 36 | $44K |
Brand drugs: 2,403 claims; generic drugs: 2,405 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deepa Taneja $5,253 ($5,253 in general payments such as food, travel and fees) from 28 companies. The largest payer was Sanofi-Aventis U.S. LLC with $2,896.
| Company | Payments | Amount |
|---|---|---|
| Sanofi-Aventis U.S. LLC SNY | 6 | $2,896 |
| Insulet Corporation PODD | 14 | $313 |
| Amgen Inc. AMGN | 13 | $265 |
| Novo Nordisk Inc NVO | 7 | $248 |
| Ascendis Pharma Endocrinology Inc ASND | 9 | $214 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $168 |
| Recordati_rare_diseases_inc. | 8 | $156 |
| Esperion Therapeutics, Inc. ESPR | 5 | $88.2 |
| Lilly USA, LLC LLY | 5 | $88.17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.